DocDollars

Esperion Therapeutics, Inc.

MI · United States · Reporting entity ID 100000771817

Total reported 2019–2025
$29.4M
#244 of 2,960 reporting companies — 0% of all reported industry payments
$13.2M in general payments across 197,050 records, plus $16.2M in research funding across 24,298 records.

How it breaks down

General payments $13,228,746
Research funding $16,207,000

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Esperion Therapeutics, Inc. reported $29.4M to US doctors and teaching hospitals from 2019 to 2025, ranking #244 of 2,960 reporting companies. 55% of that was research funding and 45% general payments such as consulting, speaking, food and travel. 197,050 general payment records and 24,298 research records were filed.

Common questions about Esperion Therapeutics, Inc.

How much has Esperion Therapeutics, Inc. paid US doctors?

Esperion Therapeutics, Inc. reported $29,435,746 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $13,228,746 in general payments, $16,207,000 in research funding.

How does Esperion Therapeutics, Inc. rank among drug and device companies?

It ranks #244 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Esperion Therapeutics, Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.